Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): Compared with the results of pyrazinamidase assay and Kyokuto PZA test

Diagnostic Microbiology and Infectious Disease

Volumn 44, Issue 4, 2002, Pages 347-352

  Aono, Akio ^a   Hirano, Kazue ^b   Hamasaki, Sonomi ^b   Abe, Chiyoji ^b  

^a Japan Anti Tuberculosis Association   (Japan)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN PNCA; PYRAZINAMIDE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ASSAY; INCUBATION TIME; INTERMETHOD COMPARISON; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUBERCULOSIS;

AMIDOHYDROLASES; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; TUBERCULOSIS;

EID: 0036959376     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00471-6     Document Type: Article

References (41)

1. Abe C., Hirano K., Wada M. Evaluation of the Mycobacteria Growth Indicator Tube system using oxygen sensitive fluorescent sensor for rapid detection of mycobacteria. Casal M. Clinical mycobacteriology. 1998;175-180 Prous Science, Barcelona.
2. Abe C., Hirano K., Tomiyama T. Simple and rapid identification of Mycobacterium tuberculosis complex by immunochromatographic assay using anti-MPB64 monoclonal antibodies. J Clin Microbiol. 37:1999;3693-3697.
3. Abe C., Aono A., Hirano K. Evaluation of the BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis isolates compared with the proportion method on solid media. Kekkaku. 76:2001;657-662.
4. Badak F.Z., Kiska D.L., Setterquist S., Hartley C., O'Connell M.A., Hopfer R.L. Comparison of Mycobacterium Growth Indicator Tube with BACTEC 460 for detection and recovery of mycobacteria from clinical specimens. J Clin Microbiol. 34:1996;2236-2239.
5. Bemer-Melchior, P., & Drugeon, H. B. (2000). Clinical evaluation of the BACTEC MGIT 960 antimycobacterial susceptibility test of Mycobacterium tuberculosis to front line drugs. RICAI Meeting, Paris, France.
6. Bergmann J.S., Woods G.L. Reliability of Mycobacteria Growth Indicator Tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin. J Clin Microbiol. 35:1997;3325-3327.
7. Becton Dickinson Microbiology Systems. (2000). BD BACTEC™ MGIT™ 960 PZA Kit.
8. Butler W.R., Kilburn J.O. Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol. 16:1982;1106-1109.
9. Casal M., Gutierrez J., Vaquero M. Comparative evaluation of the Mycobacteria Growth Indicator Tube with the BACTEC 460 TB system and Lowenstein-Jensen medium for isolation of mycobacteria from clinical specimens. Int J Tuberc Lung Dis. 1:1997;81-84.
10. Cheng S.-J., Thibert L., Sanchez T., Heifets L., Zhang Y. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis spread of a monoresistant strain in Quebec, Canada . Antimicrob Agents Chemother. 44:2000;528-532.
11. Davies A.P., Billington O.J., McHugh T.D., Mitchison D.A., Gillespie S.H. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J Clin Microbiol. 38:2000;3686-3688.
12. Hannan M.M., Desmond E.P., Morlock G.P., Mazurek G.H., Crawford J.T. Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States. J Clin Microbiol. 39:2001;647-650.
13. Heifets L., Linderholm-Levy P. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. Am Rev Respir Dis. 145:1992;1223-1225.
14. Hirano K., Takahashi M., Kazumi Y., Fukasawa Y., Abe C. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuberc Lung Dis. 78:1998;117-122.
15. Kiehn T.E., Cynamon M.H., Inderlied C.B., Roberts G.D., Siddiqi S.H., Wallace R.J., Warren N.G. Antimycobacterial susceptibility testing for Mycobacterium tuberculosis, tentative standard. NCCLS M24-T. 15:1995;1-31.
16. Konno K., Feldmann F.M., McDermott W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis. 95:1967;461-469.
17. Mackanes G.B. The intracellular activation of pyrazinamide and nicotinamide. American Review of Tuberculosis and Pulmonary Diseases. 74:1956;718-728.
18. Marttila H.J., Marjamaki M., Vyshnevskaya E., Vyshnevskiy B.I., Otten T.F., Vasilyef A.V., Viljanen M.K. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Northwestren Russia. Antimicrob Agents Chemother. 43:1999;1764-1766.
19. McClatchy J.K., Tsang A.Y., Cernich M.S. Use of pyrazinamidase activity in Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob Agents Chemother. 20:1981;556-557.
20. McDermott W., Tompsett R. Activation of pyrazinamide and nicotinamide in acid environments in vitro. American Review of Tuberculosis and Pulmonary Diseases. 70:1954;748-754.
21. Miller M.A., Thibert L., Desjardins F., Siddiqi S.H., Dascal A. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamde comparison of Bactec method with pyrazinamidase assay. J Clin Microbiol. 33:1995;2468-2470.
22. Mitchison D.A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle. 66:1985;219-225.
23. Morlock G.P., Crawford J.T., Butler W.R., Brim S.E., Sikes D., Mazurek G.H., Woodley C.L., Cooksey R.C. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 44:2000;2291-2295.
24. Palaci M.S., Ueki Y.M., Sato D.N., Da Silva Tesses M.A., Curcio M., Silva E.A.M. Evaluation of Mycobacteria Growth Indicator Tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens. J Clin Microbiol. 34:1996;762-764.
25. th General Meeting of the American Society for Microbiology: Los Angeles, California, C-16, p. 129.
26. Pfyffer G.E., Welscher H.-M., Kissling P., Cislak C., Casal M.J., Gutierrez J., Rusch-Gerdes S. Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J Clin Microbiol. 35:1997;364-368.
27. Reisner B.S., Gaston A.M., Woods G.L. Evaluation of Mycobacteria Growth Indicator Tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin. Diagn Microbiol Infect Dis. 22:1995;325-329.
28. Rusch-Gerdes S., Domehl C., Nardi G., Gismondo M.R., Welschner H.-M., Pfyffer G.E. Multicenter evaluation of the Mycobacteria Growth Indicator Tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol. 37:1999;45-48.
29. Salfinger M., Heifets L.B. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob Agents Chemother. 32:1988;1002-1004.
30. Salfinger M., Reller L.B., Demchuk B., Johnson Z.T. Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Res Microbiol. 140:1989;301-309.
31. Scorpio A., Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med. 2:1996;662-667.
32. Sharp S.E., Suarez C.A., Lemes M., Poppiti R.J. Evaluation of the Mycobacteria Growth Indicator Tube compared to Septi-Chek AFB for the detection of mycobacteria. Diagn Microbiol Infect Dis. 25:1996;71-75.
33. Stottmeier K.D., Beam R.E., Kubica G.P. Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar. Am Rev Respir Dis. 96:1967;1072-1075.
34. Suzuki K., Tsuyuguchi K., Matsumoto H., Niimi A., Tanaka E., Murayama T., Amitani R., Kuze F. Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis isolates. Kekkaku. 72:1997;187-192.
35. Tenover F.C., Crawford J.T., Huebner R.E., Geiter L.J., Horsburgh C.R., Good R.C. Guest Commentary the resurgence of tuberculosis: Is your laboratory ready? J Clin Microbiol. 31:1993;767-770.
36. Trivedi S.S., Desai S.G. Pyrazinamidase activity of Mycobacterium tuberculosis-a test of sensitivity to pyrazinamide. Tubercle. 68:1987;221-224.
37. Walters S.B., Hanna B.A. Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by Mycobacteria Growth Indicator Tube method. J Clin Microbiol. 34:1996;1565-1567.
38. Wayne L.G. Simple pyrazinamide and urease tests for routine identification of mycobacteria. Am Rev Respir Dis. 109:1974;147-151.
39. Woods G.L., Brown-Elliot B.A., Desmond E.P., Hall G.S., Heifets L., Pfyffer G.E., Plaunt M.R., Ridderhof J.C., Wallace R.J. Jr, Warren N.G., Witebsky F.G. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic Actinomycetes; tentative standard-second edition. NCCLS M24-T2. 20:2000;1-59.
40. World Health Organization. (1995). WHO reports on the Tuberculosis Epidemic. Stop TB at the source. Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
41. Yamane N., Nakasone I., Yamashita K., Toyoda K., Okazawa Y. Determination of pyrazinamide susceptibility for Mycobacterium tuberculosis by use of Middlebrook culture media and comparison with results of pyrazinamidase test. Jpn J Clin Pathol. 46:1998;479-485.